• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aging Cell . Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models

tetano

Editor, Senior Moderator
Aging Cell


. 2023 Dec 14:e14050.
doi: 10.1111/acel.14050. Online ahead of print. Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models

Takuya Tsumita[SUP] 1 [/SUP], Ryo Takeda[SUP] 1 2 [/SUP], Nako Maishi[SUP] 1 [/SUP], Yasuhiro Hida[SUP] 3 [/SUP], Michihito Sasaki[SUP] 4 [/SUP], Yasuko Orba[SUP] 4 5 [/SUP], Akihiko Sato[SUP] 4 6 [/SUP], Shinsuke Toba[SUP] 4 6 [/SUP], Wataru Ito[SUP] 1 7 [/SUP], Takahito Teshirogi[SUP] 1 8 [/SUP], Yuya Sakurai[SUP] 1 8 [/SUP], Tomohiro Iba[SUP] 9 10 [/SUP], Hisamichi Naito[SUP] 9 [/SUP], Hitoshi Ando[SUP] 10 [/SUP], Haruhisa Watanabe[SUP] 11 [/SUP], Amane Mizuno[SUP] 1 [/SUP], Toshiki Nakanishi[SUP] 1 [/SUP], Aya Matsuda[SUP] 1 [/SUP], Ren Zixiao[SUP] 1 7 [/SUP], Ji-Won Lee[SUP] 11 [/SUP], Tadahiro Iimura[SUP] 11 [/SUP], Hirofumi Sawa[SUP] 4 5 12 13 [/SUP], Kyoko Hida[SUP] 1 [/SUP]



Affiliations
Abstract

Thrombosis is the major cause of death in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and the pathology of vascular endothelial cells (ECs) has received much attention. Although there is evidence of the infection of ECs in human autopsy tissues, their detailed pathophysiology remains unclear due to the lack of animal model to study it. We used a mouse-adapted SARS-CoV-2 virus strain in young and mid-aged mice. Only mid-aged mice developed fatal pneumonia with thrombosis. Pulmonary ECs were isolated from these infected mice and RNA-Seq was performed. The pulmonary EC transcriptome revealed that significantly higher levels of viral genes were detected in ECs from mid-aged mice with upregulation of viral response genes such as DDX58 and IRF7. In addition, the thrombogenesis-related genes encoding PLAT, PF4, F3 PAI-1, and P-selectin were upregulated. In addition, the inflammation-related molecules such as CXCL2 and CXCL10 were upregulated in the mid-aged ECs upon viral infection. Our mouse model demonstrated that SARS-CoV-2 virus entry into aged vascular ECs upregulated thrombogenesis and inflammation-related genes and led to fatal pneumonia with thrombosis. Current results of EC transcriptome showed that EC uptake virus and become thrombogenic by activating neutrophils and platelets in the aged mice, suggesting age-associated EC response as a novel finding in human severe COVID-19.

Keywords: SARS-CoV-2; endothelial cells; mouse model; pathology; thrombosis.

 
Back
Top Bottom